ArticlebioRxiv : the preprint server for biology2026
SpatialFusion: A lightweight multimodal foundation model for pathway-informed spatial niche mapping.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Foundation models enable knowledge transfer across data modalities and tasks, yet foundation models for spatial biology remain in their early stages, largely centered on encoding single-cell representations in spatial context without fully integrating transcriptomic and morphological information to delineate functional niches. Here we introduce SpatialFusion, a lightweight multimodal foundation model that identifies biologically coherent microenvironments defined by distinct pathway activation patterns rather than spatial proximity alone. SpatialFusion integrates paired histopathology, gene expression, and inferred pathway activity into a unified representation. Compared with two specialist niche-detection methods and four spatial foundation models, SpatialFusion performs competitively and consistently resolves fine-grained spatial niches with unique pathway-level signatures. Applying the model to two Visium HD cohorts uncovered a pre-malignant niche in morphologically normal mucosa adjacent to colorectal tumors and revealed distinct malignant microenvironments in non-small cell lung cancer that were predictive of tumor stage. Overall, SpatialFusion offers a versatile framework for multimodal spatial analysis, enabling the discovery of new morpho-molecular niches with significant biological and clinical relevance.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.